Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: A study of 11 cases

Journal of the Peripheral Nervous System

Volumn 10, Issue 3, 2005, Pages 329-337

  Boukhris, Sami ^a   Magy, Laurent ^a   Gallouedec, Gaël ^a   Khalil, Mohamed ^a   Couratier, Philippe ^a   Gil, Juan ^a   Vallat, Jean Michel ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

CIDP; Fatigue; Nerve biopsy; Nerve conduction study; Polyneuropathy

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FATIGUE; FOLLOW UP; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIMB PAIN; MALE; MUSCLE CRAMP; NERVE BIOPSY; PARESTHESIA; PATIENT REFERRAL; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ADULT; AGED; BIOPSY; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; FATIGUE; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 27644582862     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2005.10311.x     Document Type: Article

References (34)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41:617-618.
2. Albers JW, Kelly JJ (1989). Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnosis features. Muscle Nerve 12:435-451.
3. Austin JH (1958). Recurrent polyneuropathies and their corticosteroid treatment with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157-192.
4. Berger AR, Aerskovitz S, Kaplan J (1995). Late motor involvement in cases presenting as 'chronic sensory demyelinating polyneuropathy'. Muscle Nerve 18:440-444.
5. Bosboom WMJ, Van den Berg LH, Franssen H, Giesbergen PCLM, Flach HZ, Van Putten AM, Veldman H, Wokke JHJ (2001). Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 124:2427-2438.
6. Boukhris S, Magy L, Kabore R, Mabrouk T, Li Y, Sindou P, Tabaraud F, Vallat JM (2004). Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP) - diagnosis confirmed by nerve biopsy. Clinical Neurophysiol 34:71-79.
7. Boulesteix JM, Tabaraud F, Salle JY, Vallat JM, Dumas M, Hugon J (1995). Early diagnosis of Guillain-Barré syndrome by electric stimulations of the nerve roots. Rev Neurol (Paris) 151:569-575.
8. Bromberg MB, Albers JW (1993). Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 16:262-266.
9. Chaudhuri A, Behan PO (2004). Fatigue in neurological disorders. Lancet 363:978-988.
10. Cros D, Chiappa KH, Patel S, Gominak S (1992). Acquired pure sensory demyelinating polyneuropathy: a chronic inflammatory demyelinating polyradiculoneuropathy variant? Ann Neurol 32:280.
11. Dyck PJ, Lais AC, Ohta M, Bastrom JA, Okazaki H, Groover RV (1975). Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621-637.
12. Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P (2004). Cytokine mRNA expression in patients with multiple sclerosis fatigue. Mult Scler 10:165-169.
13. Gorson KC, Allam G, Ropper AH (1997). Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48:321-328.
14. Guthrie TC, Nelson DA (1995). Influence of temperature changes on multiple sclerosis: critic review of mechanisms and research potential. J Neurol Sci 129:1-8.
15. Hughes R, Bensa S, Willison H, Van Den Berg P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A; Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2001). Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195-201.
16. Krupp LB (2003). Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 17:225-234.
17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematous. Arch Neurol 46:1121-1123.
18. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK (1999). Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677-680.
19. Magda P, Latov N, Brannagan TH, Weimer LH, Chin RL, Sander HW (2003). Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 60: 1755-1759.
20. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V (1999). Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 46:910-913.
21. Merkies ISJ, Schmitz PIM, Van der Meché FGA, Samijn JPA, Van Doom PA, for the European Inflammatory Neuropathy Cause and Treatment (INCAT) Group (1999). Fatigue in immune-mediated polyneuropathies. Neurology 53:1648-1654.
22. Mygland A, Monstadt P (2001). Chronic polyneuropathies in Vest-Agdar, Norway. Eur J Neurol 8:157-165.
23. Nicolas G, Maisonobe T, Le Forestier N, Léger JM, Bouche P (2002). Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 25:26-30.
24. Oh SJ, Joy JL, Kuruoglu R (1992). Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 55:667-680.
25. Olney RK (1999). Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 22:5225-5229.
26. Rotta FT, Sussman AT, Bradley WG, Ram Ayyar D, Sharma KR, Shebert RT (2000). The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 173:129-139.
27. Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P (2001). Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol 248:772-777.
28. Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001). Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311-324.
29. Staub F, Bogousslavsky J (2001). Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 12:75-81.
30. Tartaglia MC, Naranayan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL (2004). The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61:201-207.
31. Uncini A, Di Muzio A, De Angelis MV, Gioia S, Lugaresi A (1999). Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 110:694-698.
32. Vallat JM, Tabaraud F, Magy L, Torny F, Bernet-Bernady P, Macian F, Couratier P (2003). Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 27:478-485.
33. Van der Werf SP, Van den Broek HL, Anten HW, Bleijenberg G (2001). Experience of severe fatigue long after stroke and its relation depressive symptoms and disease characteristics. Eur Neurol 45:3-5.
34. Vollestad NK (1997). Measurement of human muscle fatigue. J Neurosci Methods 74:219-227.